Mutations of RNA and protein sequences involved in human immunodeficiency virus type 1 packaging result in production of noninfectious virus.
about
Exploiting Genetic Interference for Antiviral TherapyThe host protein Staufen1 interacts with the Pr55Gag zinc fingers and regulates HIV-1 assembly via its N-terminusGlobal changes in the RNA binding specificity of HIV-1 gag regulate virion genesisNucleocapsid and matrix protein contributions to selective human immunodeficiency virus type 1 genomic RNA packaging.Effect of mutations affecting the p6 gag protein on human immunodeficiency virus particle releaseInhibition of HIV-1 replication by a bis-thiadiazolbenzene-1,2-diamine that chelates zinc ions from retroviral nucleocapsid zinc fingersHIV type 1 Gag as a target for antiviral therapyStructural determinants and mechanism of HIV-1 genome packagingEfficient particle formation can occur if the matrix domain of human immunodeficiency virus type 1 Gag is substituted by a myristylation signalLocalization of the Vpx packaging signal within the C terminus of the human immunodeficiency virus type 2 Gag precursor proteinPosition dependence of functional hairpins important for human immunodeficiency virus type 1 RNA encapsidation in vivoInhibitors of human immunodeficiency virus type 1 zinc fingers prevent normal processing of gag precursors and result in the release of noninfectious virus particlesThe human immunodeficiency virus type 1 encapsidation site is a multipartite RNA element composed of functional hairpin structuresIs HIV-1 RNA dimerization a prerequisite for packaging? Yes, no, probably?Coordination of Genomic RNA Packaging with Viral Assembly in HIV-1Crystal structures of the trimeric human immunodeficiency virus type 1 matrix protein: implications for membrane association and assemblyCross- and Co-Packaging of Retroviral RNAs and Their ConsequencesOn the Selective Packaging of Genomic RNA by HIV-1The Life-Cycle of the HIV-1 Gag-RNA ComplexDetermination of the structure of the nucleocapsid protein NCp7 from the human immunodeficiency virus type 1 by 1H NMRThe bovine leukemia virus encapsidation signal is discontinuous and extends into the 5' end of the gag geneMultiple effects of an anti-human immunodeficiency virus nucleocapsid inhibitor on virus morphology and replication.Lipid-based delivery of combinations of antisense oligodeoxynucleotides for the in vitro inhibition of HIV-1 replicationThe in vitro ejection of zinc from human immunodeficiency virus (HIV) type 1 nucleocapsid protein by disulfide benzamides with cellular anti-HIV activityThe human immunodeficiency virus type 1 (HIV-1) nucleocapsid protein zinc ejection activity of disulfide benzamides and benzisothiazolones: correlation with anti-HIV and virucidal activitiesInhibition of multiple phases of human immunodeficiency virus type 1 replication by a dithiane compound that attacks the conserved zinc fingers of retroviral nucleocapsid proteinsA third-generation lentivirus vector with a conditional packaging systemAn intact TAR element and cytoplasmic localization are necessary for efficient packaging of human immunodeficiency virus type 1 genomic RNA.Yeast three-hybrid screening of rous sarcoma virus mutants with randomly mutagenized minimal packaging signals reveals regions important for gag interactionsInteraction of the human immunodeficiency virus type 1 nucleocapsid with actin.Inactivation of respiratory syncytial virus by zinc finger reactive compounds.Structural analysis of HIV-1 maturation using cryo-electron tomography.Sequence-specific binding of human immunodeficiency virus type 1 nucleocapsid protein to short oligonucleotides.A putative alpha-helical structure which overlaps the capsid-p2 boundary in the human immunodeficiency virus type 1 Gag precursor is crucial for viral particle assemblyThe bovine leukemia virus encapsidation signal is composed of RNA secondary structures.Particle size determinants in the human immunodeficiency virus type 1 Gag proteinAnalysis of minimal human immunodeficiency virus type 1 gag coding sequences capable of virus-like particle assembly and release.Nonreciprocal packaging of human immunodeficiency virus type 1 and type 2 RNA: a possible role for the p2 domain of Gag in RNA encapsidation.Effective induction of simian immunodeficiency virus-specific systemic and mucosal immune responses in primates by vaccination with proviral DNA producing intact but noninfectious virionsDistinct nucleic acid interaction properties of HIV-1 nucleocapsid protein precursor NCp15 explain reduced viral infectivity.
P2860
Q24288775-1B9242F6-ADBC-4946-97E8-8864061313BFQ24315925-F4A032FE-2039-4E0D-BFDA-AB2C5DF9F899Q24498694-6DE9BBDE-8AA0-48FF-8EDC-2B078AFE3590Q24523051-73CCFD3E-0E65-4A9C-9E14-12870D92A88FQ24563651-ECA96EEA-0F68-4EE2-B3AC-10BE3A82578DQ24605190-7A5868BD-BAE3-4143-B98C-0D4311D33F92Q24614498-553B30B6-EC44-4D9F-82BC-7B55A29C87B1Q24632055-3782A631-702D-4668-89A0-FEA386795211Q24645635-9E369947-F5C3-432A-ACF4-7F0BBFF499B6Q24645706-07C4C560-07D9-40A0-97A1-B8A560138783Q24678656-365F5C74-14C6-4EA3-80F3-2335561FAD7EQ24681117-6DD99DE7-A005-4125-B771-4BE6859F5B86Q24682817-A59FC69A-79C4-4591-9CE9-14FC69C3823AQ24805927-23E71884-FC65-4BC6-AFED-0BC455D88744Q26739673-5E36FD25-F874-4969-BD6C-7A8F9A7D2B94Q27732646-ABA389A2-F24E-42A4-A232-5C1B0506F8B2Q28066817-D4AB6125-2430-4941-90FB-9B4CAD60C99EQ28071505-6182F94C-CEB5-4379-B1AB-912D2EF1C26CQ28076985-0B60B4C9-D6E4-4CFE-92B3-609778D61790Q28289627-49F026A7-0520-480F-BF85-927E33DDE425Q28301200-F78D5FCA-0C8C-495C-ADBC-FB0164FB8DE2Q28343701-47DEFD2C-E41E-44B4-858D-F32D3C29AF21Q28366154-4517B845-263A-4DE4-8CA7-30BB31781866Q28378778-647B94FB-2D2A-4DE1-8493-C1283BFC09C0Q28379466-5A61A8CC-3729-42B6-A2BF-9C35F90C4160Q28379468-532F7904-09A2-42CA-B19A-4B3A18B176CCQ29616120-0741F0E9-0FB8-43E6-BD8E-CA0BAC306AEFQ30303886-42833ACB-6B35-41A0-8B5A-509E05FCB7D3Q33604687-DA8B7A0E-41AC-4957-BFB6-9759AD3EA4C1Q33643700-835C2F0D-3C1B-4B1B-8AF3-89F542FDB8A2Q33663190-75CEE128-023F-41F9-B74D-3D0EA7B98367Q33769181-1BC1554F-73CB-4FFD-A139-1E94F34B7C46Q33782302-C8C440C9-C697-4D30-ABFE-E01E791D78C3Q33782377-D56FB83B-B299-46AC-8789-ACDB167DE9D8Q33783331-26669B2A-6372-46B5-A155-11B3F28B0D47Q33783955-A51D885E-07BE-4741-9437-7D5C48CD9AC0Q33784754-C7A87323-BD48-4018-89E4-FD3635D629B4Q33785662-C26D3E57-D7B9-4063-92ED-601E33B05CEEQ33787271-16AFCF4E-4A71-4A6D-84DA-1782A84EBB68Q33791156-1D3A8595-B8D7-44F1-B4ED-BD5DF8677DEF
P2860
Mutations of RNA and protein sequences involved in human immunodeficiency virus type 1 packaging result in production of noninfectious virus.
description
1990 nî lūn-bûn
@nan
1990年の論文
@ja
1990年論文
@yue
1990年論文
@zh-hant
1990年論文
@zh-hk
1990年論文
@zh-mo
1990年論文
@zh-tw
1990年论文
@wuu
1990年论文
@zh
1990年论文
@zh-cn
name
Mutations of RNA and protein s ...... uction of noninfectious virus.
@ast
Mutations of RNA and protein s ...... uction of noninfectious virus.
@en
type
label
Mutations of RNA and protein s ...... uction of noninfectious virus.
@ast
Mutations of RNA and protein s ...... uction of noninfectious virus.
@en
prefLabel
Mutations of RNA and protein s ...... uction of noninfectious virus.
@ast
Mutations of RNA and protein s ...... uction of noninfectious virus.
@en
P2860
P1433
P1476
Mutations of RNA and protein s ...... uction of noninfectious virus.
@en
P2093
P2860
P304
P407
P577
1990-05-01T00:00:00Z